Nezam H. Afdhal serves as Executive at Spring Bank Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Nezam H. Afdhal has executed 10 insider transactions totaling $133.6K, demonstrating a bullish approach to their equity position. Their most recent transaction on Nov 23, 2016 involved receiving (via award) 13,150 shares valued at $119.9K.
Nezam H. Afdhal currently holds 53,300 shares of Spring Bank Pharmaceuticals, Inc. (SBPH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Nezam H. Afdhal has been a net buyer of SBPH stock. They have purchased $133.6K and sold $0 worth of shares.
Nezam H. Afdhal's most recent insider trade was on Nov 23, 2016, when they sold 13,150 shares at $9.12 per share.
Get notified when new Form 4 filings are submitted
| $12.50 |
| Discretionary |
| Aug 24, 2016 | SBPH | $18.4K | Purchase | 1,550 | $11.90 | Discretionary |
| Aug 24, 2016 | SBPH | $1.2K | Purchase | 100 | $11.99 | Discretionary |
| Aug 24, 2016 | SBPH | $4.2K | Purchase | 350 | $12.00 | Discretionary |
| Aug 16, 2016 | SBPH | $1.1K | Purchase | 100 | $11.49 | Discretionary |
| Aug 15, 2016 | SBPH | $20.6K | Purchase | 1,800 | $11.43 | Discretionary |
| Aug 12, 2016 | SBPH | $29.5K | Purchase | 2,600 | $11.33 | Discretionary |
| Aug 12, 2016 | SBPH | $11.3K | Purchase | 1,000 | $11.32 | Discretionary |
| Aug 10, 2016 | SBPH | $17.3K | Purchase | 1,600 | $10.81 | Discretionary |